PITTSBURGH, March 4, 2021 /PRNewswire/ -- Viatris Inc.
(NASDAQ: VTRS) today announced the company will take part in a
virtual fireside chat at the Barclays Global Healthcare Conference
on Wednesday March 10, 2021. CEO
Michael Goettler, President
Rajiv Malik and Chief Financial
Officer Sanjeev Narula will answer
questions about the company at 3:00 p.m.
ET.
Interested parties can access a live webcast of the event at
investor.viatris.com. An archived version also will be available
following the live event and can be accessed at the same location
for a limited time.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a new kind of healthcare
company, empowering people worldwide to live healthier at every
stage of life. We provide access to medicines, advance
sustainable operations, develop
innovative solutions and leverage our
collective expertise to connect more people to more
products and services through our one-of-a-kind Global
Healthcare Gateway®. Formed in November 2020 through the combination of Mylan
and Pfizer's Upjohn business, Viatris brings together
scientific, manufacturing and distribution expertise with
proven regulatory, medical and commercial capabilities to
deliver high-quality medicines to patients in more than 165
countries and territories. Viatris' portfolio comprises more
than 1,400 approved molecules across a wide range of therapeutic
areas, spanning both non-communicable and infectious diseases,
including globally recognized brands, complex generic and branded
medicines, a growing portfolio of biosimilars and a variety of
over-the-counter consumer products. With a global workforce
of approximately 45,000, Viatris is headquartered in
the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at
viatris.com and investor.viatris.com, and connect with us on
Twitter
at @ViatrisInc, LinkedIn and YouTube.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/viatris-inc-to-participate-in-barclays-global-healthcare-conference-301240835.html
SOURCE Viatris Inc.